ARTICLE | Company News
FDA wants more Bonefos data
May 12, 2005 12:45 AM UTC
Schering (FSE:SCH;SHR) said an FDA decision about an NDA for Bonefos clodronate as an adjuvant treatment for reducing the occurrence of bone metastases in stage II/III breast cancer patients will be d...